Xvivo Perfusion AB

Xvivo Perfusion AB

200.60
SEK
+4.60
(+2.35%)
4.09EPS
53.83P/E
6.94BMarket Cap
Jan 28Next Earn

Xvivo Perfusion AB Documents

Q2 FY2021 · Presentation

Xvivo Perfusion - Q2 2021 - Conference Call Deck · 21 pages

Read Xvivo Perfusion AB's results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q2 FY2021 documents